BODY & MIND INC.
company.status.inactiveCIK 1715611fmd_1DX1DCES8FM4QJ0SVEFG12KVBQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Aug 01, 2016 to Apr 30, 2024, 29 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | 3 | 5 | 6 | 27 | 23 | 23 |
| Net interest income | – | 0 | – | – | – | – | – |
| Cost of revenue | – | (1) | 3 | 4 | 14 | 16 | 17 |
| Gross profit | – | 1 | 2 | 2 | 12 | 7 | 6 |
| Compensation and benefits | – | 0 | 1 | – | – | – | – |
| Total operating expenses | – | – | – | (7) | 11 | 12 | 13 |
| Operating income | – | – | (3) | (6) | 1 | (5) | (8) |
| Interest expense | – | 0 | 1 | 0 | 0 | 1 | – |
| Other non-operating income (expense) | – | 0 | – | – | (0) | 22 | (10) |
| Income before taxes | (0) | (2) | (4) | (4) | 0 | (27) | (18) |
| Income tax expense | – | (0) | 0 | 0 | 2 | (2) | (2) |
| Net income from continuing operations | (0) | (3) | (4) | (5) | (2) | (28) | (20) |
| Net income | (0) | (2) | (4) | (5) | (2) | (28) | (21) |